If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of AGM & Approval of Recapitalisation

12 Nov 2014 11:58

RNS Number : 8465W
China Growth Opportunities Ltd
12 November 2014
 



12 November 2014

 

China Growth Opportunities Limited

(the "Company")

 

Result of Annual General Meeting

Approval of Recapitalisation and new Investing Policy

 

The Company is pleased to announce that, further to the announcement made on 20 October 2014, all resolutions at the Annual General Meeting ("AGM") put to Shareholders, held at 11 a.m. today, at the offices of Elysium Fund Management Limited, 1st Floor, Royal Chambers, St Julian's Avenue, St Peter Port, Guernsey, GY1 3JX, were duly passed.

 

The Company has therefore, inter alia:

- approved the adoption of a new Investing Policy under AIM Rule 15;

 

- approved the appointment of RFC Ambrian Limited as the Company's Nominated Adviser and Joint Broker;

 

- approved the appointment of Peterhouse Corporate Finance Limited ("Peterhouse") as Joint Broker;

 

- approved the subscription by various investors (the "Subscribers") of 201,204,820 Ordinary Shares (the "Subscription Shares") at a price of £0.003320 to raise £668,000 (the "Subscription");

 

- approved the share capital reorganisation as detailed below;

 

- approved the Rule 9 Waiver, further details as set out below; and

 

- approved the change of name to Kuala Limited.

The Company's Ordinary Shares are currently suspended from trading on AIM. Following the passing of the resolutions at the AGM the Company is pleased to confirm the appointment of RFC Ambrian Limited as the Company's Nominated Adviser and Joint Broker and accordingly trading in the Company's Ordinary Shares on AIM is expected to be restored with effect from 7.30a.m. on 13 November 2014.

 

Application has been made for the 201,204,820 Ordinary Shares issued to the Subscribers (who constitute a concert party under the UK City Code on Takeovers and Mergers) pursuant to the Subscription, to be admitted to trading on AIM.

 

The Subscription Shares will rank pari passu with the Ordinary Shares already in issue. Immediately following the issue of the Subscription Shares, the Company's total issued share capital will be 271,205,529 Ordinary Shares of 0.1p each.

 

At the AGM Shareholders of the Company also approved a share capital reorganisation. Accordingly, immediately prior to the Subscription, Ordinary Shares of the Company were sub-divided into one New Ordinary Share of 0.1 pence, and one Deferred Share of 0.9 pence. Following the Subscription, the Ordinary Shares in the Company (including the Subscription Shares) have been consolidated so that every 10 Ordinary Shares of 0.1p each in the capital of the Company, have been consolidated into one Ordinary Share of 1p each.

 

Thus, on Admission, there will be 27,120,552 Ordinary Shares of 1p each in issue. Admission of the 27,120,552 Ordinary Shares is expected to commence at 8.00 a.m. on 13 November 2014. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Further details regarding the share capital reorganisation approved by Shareholders at the AGM are set out in the notice of annual general meeting published by the Company on 20 October 2014, and which is available on the Company's website www.chinagrowthopportunities.com (the "2014 AGM Notice").

 

The change in the Company's name will be affected and announced shortly.

 

In addition to the issue of the Subscription Shares, the Company has entered into a Warrant Instrument pursuant to which the Company has issued 158,400,000 warrants to the Subscribers (the "Subscription Anti-Dilution Warrants"), pro rata to their participation in the Subscription, which can only be exercised to the extent outstanding warrants as at the date of the Subscription ("Existing Warrants") are exercised (so if 10 per cent. of Existing Warrants are exercised, a Subscriber shall be entitled to exercise 10 per cent. of their respective Subscription Anti-Dilution Warrants). Entry into the warrant instrument is conditional on admission of the Subscription Shares to trading on AIM. The exercise price is 5p per Ordinary Share and the warrants expire on 28 May 2015. Further details regarding the Existing Warrants and the Subscription Anti-Dilution Warrants are set out in the 2014 AGM Notice.

 

Additionally, the Company has agreed to issue to Peterhouse warrants to subscribe for 813,616 new Ordinary Shares, equating to 3 per cent., of the enlarged share capital of the Company, exercisable for up to 2 years at 3.32 pence per Ordinary Share.

 

Stephen Dattels has now joined the Board as Executive Chairman and Ian Burns as Non-Executive Director. Kevin McCabe and Nicholas Brooke have resigned from office, and each received £8,400 as full and final settlement for their services to the Company and will waive all claims against the Company.

 

Regent Mercantile, which is owned by a trust under which Stephen Dattels is a discretionary beneficiary, has today acquired 500,000 Ordinary Shares from each of Kevin McCabe and Nicholas Brooke at 3.32 pence per Ordinary Share. Regent Mercantile is now interested in 4,551,229 Ordinary Shares, representing 16.78 per cent. of the issued share capital of the Company.

At the AGM the waiver resolution under Rule 9 of the City Code was approved. Following the AGM, the Subscribers, constituting the concert party members, are interested in 20,120,482 Ordinary Shares, representing 74.19 per cent. of the issued share capital of the Company. The Subscribers have also been issued with 158,400,000 Subscription Anti-Dilution Warrants and as explained above, these can only be exercised in the same proportions to the extent that Existing Warrants are exercised. Immediately after the AGM, the maximum controlling position of the Subscribers, including the acquisition by Regent Mercantile, as mentioned above, and after exercising the Subscription Anti-Dilution Warrants in full, is 77.88 per cent. of the issued share capital.

Shareholders should note that the Company is now a company subject to Rule 15 of the AIM Rules for Companies and as such has until 13 November 2015 to have made an acquisition or acquisitions which constitute a reverse takeover under Rule 14 or otherwise implemented its investing policy. If it has not done so by this date trading in the Company's Ordinary Shares on AIM will be suspended pending implementation. If the Ordinary Shares remained suspended for a further 6 months from that date then trading would be cancelled.

For further information please contact:

China Growth Opportunities Limited

Elysium Fund Management Limited

 

Tel: Tel: +44 1481 810 100

RFC Ambrian Limited (Nomad and Joint Broker)

James Biddle

 

Tel: +44 (0) 20 3440 6800 

Peterhouse Corporate Finance Limited (Joint Broker)

Guy Miller / Lucy Williams

 

Tel: +44 (0) 20 7469 0930

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFLLFFZFFEFBD
Date   Source Headline
12th Jul 20216:15 pmRNSUpdate on timetable for Change of Name
9th Jul 20214:00 pmRNSResult of EGM and Change of Name
7th Jul 20217:00 amRNSFurther Investment in South West Brands Limited
6th Jul 20217:00 amRNSInvestment in cannabis healthcare company- CiiTECH
5th Jul 20217:00 amRNSNew investment - European medical cannabis company
28th Jun 20217:30 amRNSSale of Shares in Portage Biotech
28th Jun 20217:00 amRNSFurther Investment in Little Green Pharma Ltd
22nd Jun 20213:30 pmRNSNotice of EGM & Proposed Change of Name
22nd Jun 20213:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
10th Jun 20217:00 amRNSPurchase of further shares in Little Green Pharma
1st Jun 20217:00 amRNSInvestee Company Update: Yooma Wellness Inc.
28th May 20217:00 amRNSInvestee Company Update: Little Green Pharma
29th Apr 20217:00 amRNSInvestee Company Update: Yooma Wellness
12th Apr 20219:00 amRNSSpecialist Appointed to Strengthen Team
7th Apr 20214:25 pmRNSCompletion of Sale of Investment in EMMAC
1st Apr 20217:00 amRNSNew Investment in Cannabis Cultivator Company
22nd Mar 20213:26 pmRNSInvestee Company Update: Yooma Wellness
18th Mar 20211:55 pmRNSInvestee Company Update: Yooma Wellness Inc.
15th Mar 20217:00 amRNSInvestee Company Update: Leap Gaming
11th Mar 20218:00 amRNSSale of Investments in Kanabo and Cellular Goods
10th Mar 20217:00 amRNSConditional Sale of Investment in EMMAC
8th Mar 202110:21 amRNSInvestee Update: Portage Biotech & Juvenescence
3rd Mar 20217:00 amRNSNew Corporate Presentation
2nd Mar 20212:06 pmRNSInvestee Update: EMMAC Life Sciences and Yooma
1st Mar 20217:00 amRNSNew Investment in Consumer Cannabinoid Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20217:15 amRNSInvestor Presentation
26th Feb 20217:00 amRNSCorporate Update
23rd Feb 20214:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20218:15 amRNSHolding(s) in Company
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20219:37 amRNSInvestee Company Update: Little Green Pharma Ltd
16th Feb 20212:00 pmRNSPrice Monitoring Extension
16th Feb 202112:20 pmRNSInvestment in Medical Cannabis Company
12th Feb 20217:00 amRNSNew Investment in Medical Cannabis Business
11th Feb 20213:44 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Feb 202110:33 amRNSInvestee Company Update: Yooma Corp.
2nd Feb 202111:09 amRNSInvestee Company Update: Leap Gaming
1st Feb 20217:00 amRNSInvestment - CBD Brand Business, South West Brands
29th Jan 202110:40 amRNSPlacing to raise £2.1 million
26th Jan 20214:12 pmRNSInvestee Company Update: EMMAC Life Sciences
26th Jan 20212:14 pmRNSInvestee Company Update: Yooma Corp.
20th Jan 202112:00 pmRNSInvestee Update: EMMAC Life Sciences & Yooma Corp.
16th Dec 20207:00 amRNSFurther Investment in EMMAC Life Sciences Group
10th Dec 20207:00 amRNSInterim Results
30th Nov 20207:00 amRNSEd McDermott Appointed to the Board of Leap Gaming
24th Nov 20207:00 amRNSInvestee Company Update: Yooma Corp.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.